Trial Profile
A comparison of cardiovascular outcomes in postmenopausal women treated with aromatase inhibitors versus tamoxifen in breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2014
Price :
$35
*
At a glance
- Drugs Tamoxifen (Primary) ; Aromatase inhibitors
- Indications Breast cancer
- Focus Pharmacodynamics
- 22 Apr 2014 New trial record